AstraZeneca to sell AstraTech to DENTSPLY International
22 June 2011 | By AstraZeneca
AstraZeneca has agreed to sell its Astra Tech business to DENTSPLY for approximately $1.8 billion in cash...
List view / Grid view
22 June 2011 | By AstraZeneca
AstraZeneca has agreed to sell its Astra Tech business to DENTSPLY for approximately $1.8 billion in cash...
22 June 2011 | By The Scott Partnership
Novozymes Biopharma, will host a panel session at the BIO Business Forum...
21 June 2011 | By Eli Lilly and Company
Eli Lilly and Company, together with Amylin Pharmaceuticals, Inc. and Alkermes, Inc., announced that the European Commission has granted marketing authorization to BYDUREON™...
21 June 2011 | By The Scott Partnership
Exco InTouch, announced that its novel eDiary technologies have been selected by Pfizer...
21 June 2011 | By ERT
ERT, announced that Robert Kleiman, has been appointed to the role of Chief Medical Officer...
21 June 2011 | By Novartis
FDA panel voted in favor of the overall efficacy but not the overall safety of ACZ885...
21 June 2011 | By Pfizer
Pfizer Inc. announced that top-line results for Lyrica Study A0081107, demonstrated that the study met its primary endpoint...
Thermo Fisher Scientific Inc., the world leader in serving science, today announced it will show its expanded portfolio of market-leading chromatography solutions within the Thermo Scientific and Dionex booths at HPLC 2011, a first since Thermo Fisher acquired Dionex.
20 June 2011 | By Abbott
"Lupron Depot is an important treatment option for many patients..."
20 June 2011 | By Hudson Robotics
First successful installation of its newest RapidPick™ Workcell System...
20 June 2011 | By Boehringer Ingelheim
To round off its full-service capabilities for clients, Boehringer Ingelheim is expanding its capacities and capabilities in fill & finish for biopharmaceuticals at their state-of-the-art facility in Biberach, Germany, with a new filling line.
20 June 2011 | By Roche
Pivotal Phase II study with vismodegib showed positive results in people with advanced advanced basal cell carcinoma.
20 June 2011 | By Pfizer
Pfizer Inc. and Acura Pharmaceuticals Inc., announce the marketing approval from the U.S. FDA of OXECTATM (oxycodone HCl, USP) Tablets CII...
17 June 2011 | By Boehringer Ingelheim
TWYNSTA® leads to prompt and very effective reductions in blood pressure...
16 June 2011 | By Novartis
Construction of this facility represents the most significant Novartis investment in Russia...